Presented by
Description
Throughout the past 25 years, PHARMAC has had a significant impact on pharmaceutical spending patterns in New Zealand. This presentation explores how PHARMAC fits within the wider health sector, how it makes new investment decisions, and looks at some of the outcomes that come out of these decisions. Participants will gain an understanding of the flow of new proposals from application, to clinical advice, to economic review, to the final decision.
Speaker Bios
Carsten Schousboe is a Senior Health Economist at PHARMAC, his specific focus is on health technology and pharmaceutical cost modelling. He is currently working towards a PhD with Otago University focusing on the measurement of health outcomes in cost effectiveness analysis.